Cargando…
Safety and efficacy of long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection: a systematic review and meta-analysis protocol
BACKGROUND: Current antiretroviral regimens have, for the most part, achieved optimal antiretroviral efficacy and tolerability, transforming HIV infection from a deadly disease into a manageable chronic condition. However, adherence to daily oral drug intake remains an issue, as it is the most impor...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806048/ https://www.ncbi.nlm.nih.gov/pubmed/36572503 http://dx.doi.org/10.1136/bmjopen-2022-063089 |
_version_ | 1784862450722537472 |
---|---|
author | Wu, Yuan-ni Yu, Hai Lu, Lianfeng Li, Xiaodi Liu, Xiaosheng Cao, Wei Li, Taisheng |
author_facet | Wu, Yuan-ni Yu, Hai Lu, Lianfeng Li, Xiaodi Liu, Xiaosheng Cao, Wei Li, Taisheng |
author_sort | Wu, Yuan-ni |
collection | PubMed |
description | BACKGROUND: Current antiretroviral regimens have, for the most part, achieved optimal antiretroviral efficacy and tolerability, transforming HIV infection from a deadly disease into a manageable chronic condition. However, adherence to daily oral drug intake remains an issue, as it is the most important determinant for sustained viral suppression and prevention of the emergence of drug-resistant viral strains. The long-acting injection antiretroviral cabotegravir and rilpivirine combination, a novel drug delivery approach, is about to revolutionise the therapy for people living with HIV. In this protocol, we aim to generate a clinically useful summary of the interventions based on their efficacy. METHODS AND ANALYSIS: We searched the literature for eligible studies published from inception up to 16 August 2022 through PubMed, EMBASE, Cochrane Library, Scopus and ClinicalTrials.gov. Two methodologically trained researchers will select the qualified studies for data extraction independently. Cochrane Risk of Bias tool will be used to assess the risk of bias in included studies. Statistical heterogeneity will be computed by Cochrane X(2) and I(2) tests. Sensitivity analysis will be conducted to evaluate the stability of the results. Publication biases will be evaluated by Begg’s and Egger’s tests. The quality of evidence will be assessed by the Grading of Recommendations Assessment, Development and Evaluation system. The RevMan V.5.3 and Stata V.14.0 software will be applied for statistical analyses. ETHICS AND DISSEMINATION: Ethical approval will not be required for this systematic review because the data used are not linked to the individual patient. The results of this review will be disseminated by being published in a peer-reviewed journal. PROSPERO REGISTRATION NUMBER: CRD42022310414 |
format | Online Article Text |
id | pubmed-9806048 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-98060482023-01-03 Safety and efficacy of long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection: a systematic review and meta-analysis protocol Wu, Yuan-ni Yu, Hai Lu, Lianfeng Li, Xiaodi Liu, Xiaosheng Cao, Wei Li, Taisheng BMJ Open HIV/AIDS BACKGROUND: Current antiretroviral regimens have, for the most part, achieved optimal antiretroviral efficacy and tolerability, transforming HIV infection from a deadly disease into a manageable chronic condition. However, adherence to daily oral drug intake remains an issue, as it is the most important determinant for sustained viral suppression and prevention of the emergence of drug-resistant viral strains. The long-acting injection antiretroviral cabotegravir and rilpivirine combination, a novel drug delivery approach, is about to revolutionise the therapy for people living with HIV. In this protocol, we aim to generate a clinically useful summary of the interventions based on their efficacy. METHODS AND ANALYSIS: We searched the literature for eligible studies published from inception up to 16 August 2022 through PubMed, EMBASE, Cochrane Library, Scopus and ClinicalTrials.gov. Two methodologically trained researchers will select the qualified studies for data extraction independently. Cochrane Risk of Bias tool will be used to assess the risk of bias in included studies. Statistical heterogeneity will be computed by Cochrane X(2) and I(2) tests. Sensitivity analysis will be conducted to evaluate the stability of the results. Publication biases will be evaluated by Begg’s and Egger’s tests. The quality of evidence will be assessed by the Grading of Recommendations Assessment, Development and Evaluation system. The RevMan V.5.3 and Stata V.14.0 software will be applied for statistical analyses. ETHICS AND DISSEMINATION: Ethical approval will not be required for this systematic review because the data used are not linked to the individual patient. The results of this review will be disseminated by being published in a peer-reviewed journal. PROSPERO REGISTRATION NUMBER: CRD42022310414 BMJ Publishing Group 2022-12-26 /pmc/articles/PMC9806048/ /pubmed/36572503 http://dx.doi.org/10.1136/bmjopen-2022-063089 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | HIV/AIDS Wu, Yuan-ni Yu, Hai Lu, Lianfeng Li, Xiaodi Liu, Xiaosheng Cao, Wei Li, Taisheng Safety and efficacy of long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection: a systematic review and meta-analysis protocol |
title | Safety and efficacy of long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection: a systematic review and meta-analysis protocol |
title_full | Safety and efficacy of long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection: a systematic review and meta-analysis protocol |
title_fullStr | Safety and efficacy of long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection: a systematic review and meta-analysis protocol |
title_full_unstemmed | Safety and efficacy of long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection: a systematic review and meta-analysis protocol |
title_short | Safety and efficacy of long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection: a systematic review and meta-analysis protocol |
title_sort | safety and efficacy of long-acting intramuscular cabotegravir and rilpivirine in adults with hiv-1 infection: a systematic review and meta-analysis protocol |
topic | HIV/AIDS |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806048/ https://www.ncbi.nlm.nih.gov/pubmed/36572503 http://dx.doi.org/10.1136/bmjopen-2022-063089 |
work_keys_str_mv | AT wuyuanni safetyandefficacyoflongactingintramuscularcabotegravirandrilpivirineinadultswithhiv1infectionasystematicreviewandmetaanalysisprotocol AT yuhai safetyandefficacyoflongactingintramuscularcabotegravirandrilpivirineinadultswithhiv1infectionasystematicreviewandmetaanalysisprotocol AT lulianfeng safetyandefficacyoflongactingintramuscularcabotegravirandrilpivirineinadultswithhiv1infectionasystematicreviewandmetaanalysisprotocol AT lixiaodi safetyandefficacyoflongactingintramuscularcabotegravirandrilpivirineinadultswithhiv1infectionasystematicreviewandmetaanalysisprotocol AT liuxiaosheng safetyandefficacyoflongactingintramuscularcabotegravirandrilpivirineinadultswithhiv1infectionasystematicreviewandmetaanalysisprotocol AT caowei safetyandefficacyoflongactingintramuscularcabotegravirandrilpivirineinadultswithhiv1infectionasystematicreviewandmetaanalysisprotocol AT litaisheng safetyandefficacyoflongactingintramuscularcabotegravirandrilpivirineinadultswithhiv1infectionasystematicreviewandmetaanalysisprotocol |